Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
  1. 4 Shares withheld for taxes CEO and President gave up 6,780 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 263 shares (to pay taxes)
  4. 4 Shares withheld for taxes CEO and President gave up 263 shares (to pay taxes)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Shares withheld for taxes CEO and President gave up 4,725 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 6,721 shares (to pay taxes)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 162 shares (to pay taxes)
  17. 4 Shares withheld for taxes CEO and President gave up 162 shares (to pay taxes)
  18. 4 Open-market buy Chief Innovation/Tech Officer bought 1,000 shares at $7.78 ($7,780)
  19. 4 Open-market buy Chief Innovation/Tech Officer bought 2,000 shares at $8.69 ($17,380)
  20. 4 Open-market buy SVP-Chief Strategy/Dev Officer bought 1,000 shares at $8.00 ($8,000)

Page 14 of 17 · 326 filings